Correlation Between microRNA-let-7a and microRNA-10b Expression and KRAS and E-Cadherin Gene Expression in the Endometrium of Patients with Adenomyosis

In: Natural Resources for Human Health · 2026 · vol. 6(18s) , pp. 37–45 · doi:10.53365/nrfhh.3686 · W7225892145
Observational OA: closed CC0
Full text JSON View on OpenAlex View at publisher
⚙ AI-generated deep summary by qwen3.7-flash, 2026-11-17 · read from full text ⓘ

This cross-sectional study investigated the expression levels of microRNA-let-7a, miR-10b, KRAS, and E-cadherin in endometrial tissue from 32 women with and without adenomyosis. The results demonstrated that E-cadherin expression was significantly lower in patients with adenomyosis compared to controls, while no significant differences were observed for the other three molecules between the groups. Although weak negative correlations existed between miR-10b and E-cadherin in both cohorts, these associations did not reach statistical significance, indicating a lack of direct regulatory evidence in this sample. This paper is centrally about adenomyosis — specifically examining molecular markers associated with its pathogenesis in endometrial tissue.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Adenomyosis is a common benign gynecological disorder associated with chronic pelvic pain and infertility, for which current treatments are limited to symptom relief and are often unsuitable for women seeking pregnancy. Altered E-cadherin expression and dysregulation of microRNAs, including let-7a and miR-10b, have been implicated in adenomyosis pathogenesis, but their relationship with the proposed target genes KRAS and E-cadherin has not been well characterized in this condition. This cross-sectional study compared the relative expression of miRNA-let-7a, miR-10b, KRAS, and E-cadherin in endometrial tissue from women with adenomyosis (n=17) and without adenomyosis (n=15) recruited at Dr. Cipto Mangunkusumo Hospital, Jakarta [AUTHOR VERIFICATION REQUIRED: total analytical sample], and examined the associations between miRNA-let-7a and KRAS, and between miR-10b and E-cadherin, using quantitative PCR and Pearson correlation. E-cadherin expression was significantly lower in the adenomyosis group than in the non-adenomyosis group (0.39 vs 1.36; p=0.001). No significant between-group differences were found for miRNA-let-7a (p=0.288), miR-10b (p=0.320), or KRAS (p=0.509). miRNA-let-7a showed a weak negative correlation with KRAS in the non-adenomyosis group (r=-0.287, p=0.300) but not in the adenomyosis group (r=0.024, p=0.926). miR-10b showed weak-to-moderate negative correlations with E-cadherin in both groups, neither statistically significant (adenomyosis: r=-0.147, p=0.572; non-adenomyosis: r=-0.350, p=0.201). These findings support an association between reduced E-cadherin expression and adenomyosis but do not establish a direct regulatory relationship between the investigated microRNAs and their proposed target genes. Larger, molecularly stratified studies with functional validation are warranted.
Full text 2,012 characters · extracted from oa-doi-fallback · click to expand
Correlation Between microRNA-let-7a and microRNA-10b Expression and KRAS and E-Cadherin Gene Expression in the Endometrium of Patients with Adenomyosis Main Article Content Abstract Adenomyosis is a common benign gynecological disorder associated with chronic pelvic pain and infertility, for which current treatments are limited to symptom relief and are often unsuitable for women seeking pregnancy. Altered E-cadherin expression and dysregulation of microRNAs, including let-7a and miR-10b, have been implicated in adenomyosis pathogenesis, but their relationship with the proposed target genes KRAS and E-cadherin has not been well characterized in this condition. This cross-sectional study compared the relative expression of miRNA-let-7a, miR-10b, KRAS, and E-cadherin in endometrial tissue from women with adenomyosis (n=17) and without adenomyosis (n=15) recruited at Dr. Cipto Mangunkusumo Hospital, Jakarta [AUTHOR VERIFICATION REQUIRED: total analytical sample], and examined the associations between miRNA-let-7a and KRAS, and between miR-10b and E-cadherin, using quantitative PCR and Pearson correlation. E-cadherin expression was significantly lower in the adenomyosis group than in the non-adenomyosis group (0.39 vs 1.36; p=0.001). No significant between-group differences were found for miRNA-let-7a (p=0.288), miR-10b (p=0.320), or KRAS (p=0.509). miRNA-let-7a showed a weak negative correlation with KRAS in the non-adenomyosis group (r=-0.287, p=0.300) but not in the adenomyosis group (r=0.024, p=0.926). miR-10b showed weak-to-moderate negative correlations with E-cadherin in both groups, neither statistically significant (adenomyosis: r=-0.147, p=0.572; non-adenomyosis: r=-0.350, p=0.201). These findings support an association between reduced E-cadherin expression and adenomyosis but do not establish a direct regulatory relationship between the investigated microRNAs and their proposed target genes. Larger, molecularly stratified studies with functional validation are warranted.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

openalex
last seen: 2026-11-20T06:09:37.170340+00:00
unpaywall
last seen: 2026-11-20T08:37:33.920708+00:00
License: CC0 · commercial use OK